HomeInsightsEPS

Aurobindo Pharma Ltd EPS

Aurobindo Pharma Ltd EPS

stocks purchased

₹ 1.7 Cr

Volume Transacted

(Nov 7, 2024)

stocks purchased

12.3 K

Stocks Traded

(Nov 7, 2024)

Last Updated on: Nov 08, 2024

Image

Aurobindo Pharma Ltd

NSE: AUROPHARMA

EPS

₹ 61.22

Last updated on: Nov 07, 2024

Key Highlights

  • The Earning per Share of Aurobindo Pharma Ltd is ₹ 61.22 as of 07 Nov 24.
  • The Earning per Share of Aurobindo Pharma Ltd changed from ₹ 8.88 to ₹ 15.69 over 9 quarters. This represents a CAGR of 28.79% .

Historical Earning per Share of Aurobindo Pharma Ltd

No data available

* All values are in

Company Fundamentals for Aurobindo Pharma Ltd

Market Cap

79,131 Cr

EPS

61.2

P/E Ratio (TTM) *

22.1

P/B Ratio (TTM) *

2.7

Day’s High *

1399.7

Day’s Low

1346.0

DTE *

0.2

ROE *

10.6

52 Week High

1592.55

52 Week Low

903.8

ROCE *

12.8

Market Price Over Time

1M

1Y

3Y

5Y

Monitoring Aurobindo Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
07 Nov 20241350.5
06 Nov 20241394.65
05 Nov 20241396.1
04 Nov 20241407.25
01 Nov 20241401.1
31 Oct 20241396
30 Oct 20241404.7
29 Oct 20241412.65
28 Oct 20241433.85
25 Oct 20241427.15

SWOT Analysis Of Aurobindo Pharma Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Aurobindo Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Aurobindo Pharma Ltd

Market Value

79,131

Asset Value

25,059

2.2 X

Value addition

* All values are in Rupees

Competitive Comparison of EPS

Company NameEPSMarket Cap (INR Cr.)
Aurobindo Pharma Ltd6179,131
Sun Pharmaceuticals Industries Ltd464,29,841
Divis Laboratories Ltd631,58,179
Cipla Ltd571,27,063
Mankind Pharma Ltd521,09,234
Dr Reddys Laboratories Ltd631,07,398

Historical Market Cap of Aurobindo Pharma Ltd

No data available

* All values are in crore

Historical Revenue of Aurobindo Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Aurobindo Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Aurobindo Pharma Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Aurobindo Pharma Ltd News Hub

News

Aurobindo Pharma to table results

Aurobindo Pharma will hold a meeting of the Board of Directors of the Company on 9 Novembe...

Read more

02 Nov 202412:52

News

Aurobindo Pharma completes acquisition of balance 49% stake in GLS Pharma

Aurobindo Pharma has completed the acquisition of balance 49% stake in its subsidiary, GLS...

Read more

25 Oct 202419:30

News

Aurobindo Pharma Ltd spurts 1.19%, up for fifth straight session

Aurobindo Pharma Ltd gained for a fifth straight session today. The stock is quoting at Rs...

Read more

09 Oct 202413:00

News

Aurobindo Pharma's step down subsidiary to divest its entire stake in a South African JV

Aurogen South Africa, (Aurogen) a wholly owned step-down subsidiary of Aurobindo Pharma in...

Read more

05 Oct 202410:19

News

Aurobindo Pharma's step down subsidiary to divest its entire stake in JV 'Novagen'

Aurogen South Africa (Aurogen), a wholly owned step-down subsidiary of Aurobindo Pharma in...

Read more

05 Oct 202410:21

News

Auro Pharma gets USFDA nod for urinary tract infections drug.

The approved drug is bioequivalent and therapeutically equivalent to the reference listed ...

Read more

03 Oct 202414:58

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

Credit Report 2024

dropdown
download

Concalls

June 2023

TranscriptPPT

June 2022

TranscriptPPT

Aug 2021

PPT

June 2021

TranscriptPPT

June 2020

TranscriptPPT

Jan 2020

PPT

FAQs for EPS of Aurobindo Pharma Ltd

What is the EPS of Aurobindo Pharma Ltd stock?

The Earnings Per Share (EPS) of Aurobindo Pharma Ltd is 61.22. An EPS is the amount of net income attributed to each share of a common stock.

How is Aurobindo Pharma Ltd EPS calculated?

The EPS of Aurobindo Pharma Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Aurobindo Pharma Ltd report its EPS?

Aurobindo Pharma Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Aurobindo Pharma Ltd EPS?

Factors that influence the EPS of Aurobindo Pharma Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Aurobindo Pharma Ltd EPS growth indicate future performance?

Yes, consistent growth in Aurobindo Pharma Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*